D. E. Shaw & Co., Inc. Applied Genetic Technologies Corp Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.69 - $4.92 $147,148 - $269,133	-54,702 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.59 - $4.16 $8,288 - $13,312	-3,200 Reduced 5.53%	54,702 $228,000
Q2 2019 Aug 14, 2019	BUY	$3.6 - $4.78 $37,184 - $49,372	10,329 Added 21.71%	57,902 $219,000
Q1 2019 May 15, 2019	BUY	$2.62 - $4.44 $55,124 - $93,417	21,040 Added 79.3%	47,573 $199,000
Q4 2018 Feb 14, 2019	SELL	$2.28 - $7.15 $64,038 - $200,822	-28,087 Reduced 51.42%	26,533 $66,000
Q3 2018 Nov 14, 2018	BUY	$3.85 - $7.35 $86,856 - $165,816	22,560 Added 70.37%	54,620 $399,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.65 $65,704 - $100,332	17,758 Added 124.16%	32,060 $119,000
Q1 2018 May 15, 2018	SELL	$3.65 - $5.2 $6,161 - $8,777	-1,688 Reduced 10.56%	14,302 $55,000
Q4 2017 Feb 14, 2018	BUY	$3.4 - $4.15 $54,366 - $66,358	15,990	15,990 $58,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.